Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samer S. Kabbani

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Cardiovascular Medicine|November 1, 2002
Pericardial DiseasesSamer S. Kabbani, Martin M. LeWinter
The American Journal of Cardiology|April 2, 2003
Usefulness of platelet reactivity before percutaneous coronary intervention in determining cardiac risk one year laterSamer S Kabbani, Matthew W Watkins, Taka Ashikaga, et al.
The American Journal of Cardiology|February 28, 2002
Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventionsSamer S Kabbani, Atul Aggarwal, Edward F Terrien, et al.
The American Journal of Cardiology|September 18, 2004
Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosisFriederike K Keating, Deborah A Whitaker, Samer S Kabbani, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 31, 2002
Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular riskAtul Aggarwal, Samer S Kabbani, Jeffery M Rimmer, et al.
The American Journal of Cardiology|December 14, 2002
Enhanced early inhibition of platelet aggregation with an increased bolus of tirofibanDavid J Schneider, Howard C Herrmann, Nasser Lakkis, et al.
The American Journal of Cardiology|February 5, 2003
Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofibanDavid J Schneider, Howard C Herrmann, Nasser Lakkis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Cardiovascular Medicine|November 1, 2002
Pericardial DiseasesSamer S. Kabbani, Martin M. LeWinter
The American Journal of Cardiology|April 2, 2003
Usefulness of platelet reactivity before percutaneous coronary intervention in determining cardiac risk one year laterSamer S Kabbani, Matthew W Watkins, Taka Ashikaga, et al.
The American Journal of Cardiology|February 28, 2002
Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventionsSamer S Kabbani, Atul Aggarwal, Edward F Terrien, et al.
The American Journal of Cardiology|September 18, 2004
Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosisFriederike K Keating, Deborah A Whitaker, Samer S Kabbani, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 31, 2002
Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular riskAtul Aggarwal, Samer S Kabbani, Jeffery M Rimmer, et al.
The American Journal of Cardiology|December 14, 2002
Enhanced early inhibition of platelet aggregation with an increased bolus of tirofibanDavid J Schneider, Howard C Herrmann, Nasser Lakkis, et al.
The American Journal of Cardiology|February 5, 2003
Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofibanDavid J Schneider, Howard C Herrmann, Nasser Lakkis, et al.
Pageof 1